1Lan LG. Adult varicella pneumonia that responded to combined acyclovir and steroid therapy[J]. Med J Malaysia,1999,54(2):270-272.
2Brown TJ, McCrary M, Tyring SK. Antiviral agents: Nonantiretroviral drugs[J]. J Am Acad Dermatol, 2002, 47(4):581-599.
3Lin P, Torres G, Tyring SK. Changing paradigms in dermatology:antivirals in dermatology[J]. Clin Dermatol, 2003, 21(5): 426-446.
4De Clercq E. Antiviral drugs in current clinical use[J]. J Clin Virol, 2004, 30(2): 115-133.
5Pereira CF, Paridaen JT. Anti-HIV drug development-an overview[J]. Curr Pharm Des, 2004, 10(32): 4005-4037.
6Majewski S, Jablonska S. New treatments for cutaneous human papillomavirus infection[J]. J Eur Acad Dermatol Venereol, 2004,18(3): 262-264.
7Park KC, Han WS. Viral skin infections: diagnosis and treatment considerations[J]. Drugs, 2002, 62(3): 479-490.
8Rivera A, Tyring SK. Therapy of cutaneous human papillomavirus infections[J]. Dermatol Ther, 2004, 17(6): 441-448.
9Seiter S, Ugurel S, Tilgen W, et al. Use of high-ddose methylprednisolone pulse therapy in patients with progressive and stable vitiligo [ J ]. Int J Dermatol, 2000,39 ( 8 ) : 624 - 627.
10Hann SK, Par R, Chung KY, et al. Peripheral blood lymphocyte inbalance in koreans with active vitiligo [ J ]. Int J Dermatol, 1993,32 (4) :286 -289.
